The Parkinson's Podcast

Deep brain stimulation, or DBS, raises a lot of questions, including what it is, who it's for, when the best time for it is, and what living with it is actually like. This episode brings the best of six Davis Phinney Foundation conversations on DBS into one twenty-minute walk through the whole journey, from the basics to what life is like years after surgery.
You'll hear from two neurosurgeons, two movement disorder specialists, and three people who have lived with DBS for years.
Dr. Kara Beasley, DO, is a fellowship-trained functional and restorative neurosurgeon who has practiced in Boulder, CO since in 2012. Dr. Beasely also holds a master's degree in biomedical ethics.
Dr. Chengyuan Wu, MD, is Professor of Neurological Surgery and Radiology at Thomas Jefferson University in Philadelphia, where he is Division Chief of Epilepsy and Neuromodulation Neurosurgery and directs the fellowship programin stereotactic and functional neurosurgery.
Dr. Delaram Safarpour, MD, is Associate Professor of Neurology at Oregon Health & Science University and medical director of the deep brain stimulation program at the OHSU Brain Institute.
Dr. Joohi Jimenez-Shahed, MD, is Medical Director of Movement Disorders Neuromodulation and Brain Circuit Therapeutics at the Icahn School of Medicine at Mount Sinai, and former chair of the Davis Phinney Foundation's Science Advisory Board.
Jill Ater was diagnosed with Parkinson's at 42, in 2005, and had DBS surgery in 2013 and 2015, one side at a time.
Marty Acevedo had DBS surgery in 2016 and has been active in the Parkinson's Association of San Diego. 
Kevin Kwok, PharmD, is a retired biopharmaceutical executive who was diagnosed with young-onset Parkinson's in his late forties and chose DBS in 2013. He has served on the Davis Phinney Foundation's Board of Directors since 2015.
For more on DBS and living well with Parkinson's, visit dpf.org.

Learn more about Parkinson's and find support: https://dpf.org 

Researchers are exploring a growing number of potential disease-modifying therapies for Parkinson's. But what does "disease-modifying" actually mean, and what progress is being made? 

In this podcast, Chris Krueger of the Davis Phinney Foundation talks with Dr. Lorraine Kalia, a neurologist and Parkinson's researcher, about the science behind disease modification and why finding therapies that change the course of Parkinson's is so challenging.  

Topics discussed include research targeting alpha-synuclein, inflammation, genetics, mitochondria, gene therapy, and stem cells, while also addressing common questions about experimental and unproven treatments. Dr. Kalia closes with a hopeful message: while researchers continue working toward tomorrow's breakthroughs, there are meaningful steps people with Parkinson's can take today to support their health, well-being, and quality of life. 
This episode was produced with support from AskBio.
Speaker Bio:

Lorraine Kalia, MD, PhD, FRCPC is a scientist at the Toronto Western Research Institute and Tanz Centre for Research in Neurodegenerative Diseases. She is also a neurologist specializing in Parkinson's disease and related movement disorders at the Toronto Western Hospital. She is an assistant professor in the Division of Neurology, Department of Medicine at the University of Toronto.  

Sign up for updates on webinars, events, and resources for the Parkinson's community: https://dpf.org/newsletter-signup

Learn more about Parkinson's and find support: https://dpf.org
In part two of this conversation from our Live Well Today webinar series, Davis Phinney Foundation's Chris Krueger and Richelle Flanagan, a registered dietitian living with young onset Parkinson's, cover gut motility, including constipation, an under-recognized pelvic floor problem, and gastroparesis, address the dairy question, and explain why the Mediterranean diet has the strongest research support for people with Parkinson's. The conversation also covers sugar and insulin resistance, probiotics, alcohol, and how to eat well without guilt when things don't go to plan.
Richelle Flanagan is a registered dietitian with over 20 years' experience. She was diagnosed with Parkinson's in 2017, when she was 46, after noticing symptoms while 3 months pregnant with her daughter. In addition to her interest in diet and nutrition, she is passionate about the unmet needs of women with Parkinson's. She is a co-founder of the Women's Parkinson's Project and My Moves Matter, a digital health app to meet the specific needs of women living with Parkinson's.
Learn more about Richelle's work at https://www.mymovesmatter.com
Sign up for updates on webinars, events, and resources for the Parkinson's community: https://dpf.org/newsletter-signup

Learn more about Parkinson's and find support: https://dpf.org
In part one of this two-part conversation from our Live Well Today webinar series, Davis Phinney Foundation's Chris Krueger sits down with Richelle Flanagan, a registered dietitian living with young onset Parkinson's, to discuss how protein interacts with levodopa and why meal timing affects how well your medication works, which key nutrients people with Parkinson's are most commonly deficient in, and why getting your levels checked matters. The conversation also covers iron and magnesium timing, protein redistribution, intermittent fasting, and fueling for exercise and fatigue.
Richelle Flanagan is a registered dietitian with over 20 years' experience. She was diagnosed with Parkinson's in 2017, when she was 46, after noticing symptoms while 3 months pregnant with her daughter. In addition to her interest in diet and nutrition, she is passionate about the unmet needs of women with Parkinson's. She is a co-founder of the Women's Parkinson's Project and My Moves Matter, a digital health app to meet the specific needs of women living with Parkinson's.
Learn more about Richelle's work at https://www.mymovesmatter.com
Sign up for updates on webinars, events, and resources for the Parkinson's community: https://dpf.org/newsletter-signup

Learn more about Parkinson's and find support: https://dpf.org
Although a tremor is the most well-known symptom of Parkinson's, a tremor may not be the earliest symptom. Symptoms like loss of smell, constipation, acting out dreams, anxiety, and changes in handwriting can show up years before a diagnosis. Cognitive neurologist Dr. Jeffrey Maneval joins Chris Krueger to walk through the most common early signs, why Parkinson's is so often confused with conditions that mimic it, and the tests that can bring clarity, from sleep studies and DaTscans to skin biopsy and genetic testing.
You don't have to wait for a formal diagnosis to start treating symptoms. Dr. Maneval discusses how early interventions, including physical therapy, Parkinson's boxing, voice therapy, and mental health support, can help you live well today, even before you have a diagnosis.
Dr. Jeffrey Maneval is a board-certified neurologist at MaineHealth specializing in cognitive disorders, including dementia, Alzheimer's disease, and Parkinson's disease. As Director of Cognitive and Behavioral Neurology, he is dedicated to advancing patient care, education, and research to improve the lives of people living with neurological conditions.
Sign up for updates on webinars, events, and resources for the Parkinson's community: https://dpf.org/newsletter-signup
This episode is sponsored by CND Life Sciences, the developer and provider of the Syn-One skin biopsy test.